E
Enric Condom Mundo
Researcher at Bellvitge University Hospital
Publications - 7
Citations - 153
Enric Condom Mundo is an academic researcher from Bellvitge University Hospital. The author has contributed to research in topics: Fluorescence in situ hybridization & Chromophobe Renal Cell Carcinoma. The author has an hindex of 6, co-authored 7 publications receiving 100 citations. Previous affiliations of Enric Condom Mundo include University of Barcelona.
Papers
More filters
Journal ArticleDOI
Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?
Ondrej Hes,Enric Condom Mundo,Kvetoslava Peckova,José I. López,Petr Martinek,Tomas Vanecek,Giovanni Falconieri,Abbas Agaimy,Whitney Davidson,Fredrik Petersson,Stela Bulimbasic,Ivan Damjanov,Mireya Jimeno,Monika Ulamec,Miroslav Podhola,Maris Sperga,Maria Pane Foix,Ksenya V. Shelekhova,Kristyna Kalusova,Milan Hora,Pavla Rotterova,Ondrej Daum,Kristyna Pivovarcikova,Michal Michal +23 more
TL;DR: Present microscopic, immunohistochemical, and molecular genetic data strongly support the view that BSARCC is a distinctive and peculiar morphologic variant of papillary RCC.
Journal ArticleDOI
Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature.
Kvetoslava Peckova,Petr Martinek,Chisato Ohe,Naoto Kuroda,Stela Bulimbasic,Enric Condom Mundo,Delia Perez Montiel,José I. López,Ondrej Daum,Pavla Rotterova,Bohuslava Kokoskova,Magdalena Dubova,Kristyna Pivovarcikova,Kevin Bauleth,Petr Grossmann,Milan Hora,Kristyna Kalusova,Whitney Davidson,David Slouka,Sulc Miroslav,Petr Buzrla,Mirka Hynek,Michal Michal,Ondrej Hes +23 more
TL;DR: Eighteen cases of CRCC with morphologic features suggestive of neuroendocrine differentiation were selected from among 624 CRCCs in the authors' registry, and poorly preserved neuro endocrine granules only in 2 of 4 analyzed CRCCNDs.
Journal ArticleDOI
Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma.
Reza Alaghehbandan,Jan Stehlik,Kiril Trpkov,Cristina Magi-Galluzzi,Enric Condom Mundo,Maria Pane Foix,Daniel M. Berney,Mathilde Sibony,Saul Suster,Abbas Agaimy,Delia Perez Montiel,Kristyna Pivovarcikova,Kvetoslava Michalova,Ondrej Daum,Ondrej Ondič,Pavla Rotterova,Martin Dusek,Milan Hora,Michal Michal,Ondrej Hes +19 more
TL;DR: PD-1/PD-L1 expression in FH-RCC is restricted to a proportion of cases which may benefit from targeted therapies, and this is the first study to assess the expression of programmed death-1 ( PD-1) receptor/PD -1 ligand (PD- L1) in Fh-R CC.
Journal ArticleDOI
Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant
Maria Pane Foix,Maria Pane Foix,Ana Dunatov,Petr Martinek,Enric Condom Mundo,Enric Condom Mundo,Saul Suster,Maris Sperga,José I. López,Monika Ulamec,Stela Bulimbasic,Delia Perez Montiel,Reza Alaghehbandan,Kvetoslava Peckova,Krystina Pivovarcikova,Daum Ondrej,Pavla Rotterova,Faruk Skenderi,Kristyna Prochazkova,Martin Dusek,Milan Hora,Michal Michal,Ondrej Hes +22 more
TL;DR: Molecular genetic examination revealed multiple chromosomal losses in two fifths analyzable tumors, while three cases showed no chromosomal numerical aberrations and the immunophenotype of ChR CC is identical with that of conventional ChRCC.
Journal ArticleDOI
Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells.
Manuel Lora Gonzalez,Reza Alaghehbandan,Krystina Pivovarcikova,Kvetoslava Michalova,Joanna Rogala,Petr Martinek,Maria Pane Foix,Enric Condom Mundo,Eva Comperat,Monika Ulamec,Milan Hora,Michal Michal,Ondrej Hes +12 more
TL;DR: The aim of this study was to assess CK7 immunoreactivity within the spectrum of clear cell renal neoplasms, including clear cell RCC, multicystic kidney neoplasm of low malignant potential and clear cell papillary RCC‐like tumours.